Singapore sovereign wealth fund GIC to invest US$75 million in Chinese drug maker Ascletis’ Hong Kong IPO

Ascletis Pharma, the first biotechnology firm to file for an IPO in Hong Kong following recent listing reforms, has secured commitment from Singapore sovereign wealth manager GIC to become a cornersto…
( read original story …)


Related Post

Mortgage corp eyes infrastructure
views 5
Government-owned Hong Kong Mortgage Corporation is...
HSBC appoints new president and CEO for PHL
views 16
Prior to this, he also worked in several roles for...
This Hong Kong Food Startup Hires the Elderly to P...
views 14
Like many large cities around the world, Hong Kong...
Don’t be put off by a softening property mar...
views 15
Amid the sell-off in stock markets around the worl...
Hong Kong is Asia’s Fastest Growing Hotel Ma...
views 14
According to the latest Property Market Monitor re...
Global Equity Rout Derails IPOs From Spain to Hong...
views 15
OCC Cables Ltd. on Friday said it will no longer p...
Global Equities’ Rout Derails IPO Plans From...
views 16
The volatility in global equity markets derailed m...
Tesla Has a New 50-Stall Charging Station in Hong ...
views 15
Since Hong Kong’s administration scrapped tax ince...
FrieslandCampina Hong Kong wins two bronze awards ...
views 14
HONG KONG, CHINA - Media OutReach - October 15, 20...
Hong Kong is Rocking Fintech
views 18
Last month, CI reported on the fact that 29 entiti...